Minimizing Hemorrhage Risk Strategies in Cervical Pregnancy-Stepwise Pharmacologic Priming and Delayed Surgical...

Area of Science:

• Reproductive Medicine
• Gynecologic Surgery
• Medical Imaging

Background:

• Cervical pregnancy (CP) and heterotopic cervical pregnancy (HCP) are rare, high-risk conditions.
• Traditional management often involves radical intervention, leading to hemorrhage and fertility loss.
• There is a need for fertility-preserving management strategies.

Purpose of the Study:

• To review current evidence on conservative, fertility-preserving management of CP and HCP.
• To present a stepwise pharmacologic protocol for managing these conditions.

Main Methods:

• Conducted a narrative literature review using PubMed, Scopus, and Web of Science.
• Searched for terms including CP, HCP, methotrexate, mifepristone, misoprostol, uterine artery embolization, hysteroscopy, and Doppler ultrasound.
• Integrated an institutional case study employing pharmacologic priming, Doppler surveillance, and delayed evacuation.

Main Results:

• Evidence supports multi-modal conservative strategies combining methotrexate ± mifepristone, timed with Doppler-confirmed vascular regression.
• Adjuncts like misoprostol, hysteroscopy, and uterine artery embolization reduce hemorrhage risk while preserving fertility.
• An incremental dosing strategy of mifepristone followed by methotrexate, with Doppler-guided vascular involution and delayed curettage, resulted in minimal blood loss.

Conclusions:

• Imaging-guided conservative management is effective in reducing hemorrhagic complications and preserving fertility in CP/HCP.
• Further multicenter registries and standardized Doppler-based protocols are essential for optimizing outcomes.
• This approach offers a promising alternative to radical interventions.